Survival outcome in HER2-amplified metastatic colorectal cancer (mCRC).

Sawada, K; Okamoto, W; Nakamura, Y; Yamanaka, T; Yuki, S; Yoshino, T; Komatsu, Y; Sakamoto, N; Fujii, S

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (4):